85 assets in High Grade B-Cell Lymphoma

Therapeutic assets addressing High Grade B-Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Loncastuximab Tesirine High Grade B-Cell Lymphoma	Universität Münster	P2	CCC (48)
Methotrexate High Grade B-Cell Lymphoma	Northwestern University	P1/2	CCC (48)
tc011 High Grade B-Cell Lymphoma	TICAROS Co., Ltd.	P1/2	CCC (48)
Retifanlimab High Grade B-Cell Lymphoma	University of Washington	P1/2	CC (47)
Efineptakin Alfa High Grade B-Cell Lymphoma	NeoImmuneTech	P1	CC (46)
1-118-Signal regulatory protein ? (human) fusion protein with immunoglobulin G4 [128-proline] (human ?4-chain C region C-terminal fragment), dimer High Grade B-Cell Lymphoma	Mayo Clinic	P2	CC (45)
Blinatumomab High Grade B-Cell Lymphoma	M.D. Anderson Cancer Center	P1/2	CC (45)
Idp-121 High Grade B-Cell Lymphoma	IDP Discovery Pharma S.L.	P1/2	CC (45)
Inotuzumab Ozogamicin High Grade B-Cell Lymphoma	M.D. Anderson Cancer Center	P1/2	CC (45)
Mercaptopurine Anhydrous High Grade B-Cell Lymphoma	M.D. Anderson Cancer Center	P1/2	CC (45)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer High Grade B-Cell Lymphoma	National Cancer Institute (NCI)	P2	CC (44)
1928z1xx trac t cell High Grade B-Cell Lymphoma	Memorial Sloan Kettering Cancer Center	P1	CC (43)
Anti-Cd19-Car Cmv-Specific T-Lymphocytes High Grade B-Cell Lymphoma	City of Hope Medical Center	P1	CC (43)
c402-cd19-car High Grade B-Cell Lymphoma	Shanghai Exuma Biotechnology Ltd.	P1	CC (43)
cd22 car-transduced t cells High Grade B-Cell Lymphoma	Sumithira Vasu	P1	CC (43)
crc01 High Grade B-Cell Lymphoma	Curocell Inc.	P1/2	CC (43)
eb103 High Grade B-Cell Lymphoma	Estrella Biopharma, Inc.	P1/2	CC (43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes High Grade B-Cell Lymphoma	Roswell Park Cancer Institute	P1	CC (43)
Gf-Cart01 High Grade B-Cell Lymphoma	GenomeFrontier Therapeutics TW Co., Ltd.	P1	CC (43)
Immunoglobulin G4, Anti-(Human Colony-Stimulating Factor 1 Receptor) (Human-Rattus Norvegicus Monoclonal Sndx-6352 .Gamma.4-Chain), Disulfide With Human-Rattus Norvegicus Monoclonal Sndx-6352 .Kappa.-Chain, Dimer High Grade B-Cell Lymphoma	Northside Hospital, Inc.	P1	CC (43)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine High Grade B-Cell Lymphoma	City of Hope Medical Center	P1	CC (43)
Vnx-101 High Grade B-Cell Lymphoma	Vironexis Biotherapeutics Inc.	P1/2	CC (43)
ace1831 High Grade B-Cell Lymphoma	Acepodia Biotech, Inc.	P1	CC (42)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes High Grade B-Cell Lymphoma	City of Hope Medical Center	P1	CC (41)
Apamistamab High Grade B-Cell Lymphoma	Memorial Sloan Kettering Cancer Center	Early P1	C (39)
cd79b-19 car t cells High Grade B-Cell Lymphoma	Marcela V. Maus, M.D.,Ph.D.	P1	C (39)
Clic-2201 High Grade B-Cell Lymphoma	British Columbia Cancer Agency	P1	C (39)
Copanlisib High Grade B-Cell Lymphoma	National Cancer Institute (NCI)	P1	C (39)
P-Cd19Cd20-Allo1 High Grade B-Cell Lymphoma	Poseida Therapeutics, Inc.	P1	C (39)
Rimiducid High Grade B-Cell Lymphoma	Poseida Therapeutics, Inc.	P1	C (39)
Sgr-1505 High Grade B-Cell Lymphoma	Schrödinger, Inc.	P1	C (39)
Surovatamig High Grade B-Cell Lymphoma	AstraZeneca	P1	C (39)
Synkir-310 High Grade B-Cell Lymphoma	Verismo Therapeutics	P1	C (39)
Allogeneic Natural Killer Cells High Grade B-Cell Lymphoma	Paolo Caimi, MD	P1	C (37)
mdx2003 High Grade B-Cell Lymphoma	ModeX Therapeutics, An OPKO Health Company	P1/2	NR ()

Showing 51 to 85 of 85 assets

PreviousPage 2 of 2Next